Proteomic signatures associated with p53 mutational status in lung adenocarcinoma. - Test2 - elhamkhani - TriplyDB

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

http://www.wikidata.org/entity/Q35492010

about

Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Functional variomics and network perturbation: connecting genotype to phenotype in cancer.PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors.Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor.p53 and metabolism: from mechanism to therapeutics.

P2860

Q37190411-B7FE6985-4B1F-49F5-9061-EBDC4E447B1E Q38577674-0D4C56B7-E268-4254-859E-CE1036CFAEF3 Q38708958-1B67E182-21CE-4A0A-BE81-7C56E3246788 Q38807302-3E6711D6-5468-4FDD-8E79-D16DA1030219 Q39201399-C38C578A-615A-44C3-BB87-0BA4D3CA6679 Q39368524-0A783922-BBD0-4B5A-84D6-DB8EF15C9D60 Q53076500-ABF2B04C-EB5E-446A-992A-48B73F03857C Q55002919-89EBF944-BA1C-4CCB-B19A-A341E6B34595

P2860

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

http://www.wikidata.org/entity/Q35492010

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@ast

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@en

type

label

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@ast

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@en

prefLabel

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@ast

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@en

P1433

Q35492010-6A999BA0-60E8-4126-860B-5EADAAF05674

P1476

Q35492010-D0C359A4-CBF1-4A06-8034-567F8FE75772

P2093

Q35492010-0A7D2B17-4242-480A-BB54-146E428AA5D7

Q35492010-11FE1872-14A4-4EAB-8100-DC5EF478425A

Q35492010-3E7EA117-0F6F-42B0-888C-C0B6A2E147F8

Q35492010-52A89105-F61A-4ADC-92FD-D238B35BD70D

Q35492010-9A0BB8E5-D27C-4A0B-B87E-B0CD6DF1D7CE

P2860

Q35492010-01E51360-A62A-443C-B8F6-E032FA501F03

Q35492010-02676E4A-C6F7-455A-98D3-5AAE93BCB66B

Q35492010-08C728E8-7D4B-430F-AC8C-0EC9F9458010

Q35492010-0F4783E1-E675-42C2-A7E7-352172241C32

Q35492010-0F8E4291-BAF8-4DF0-85E9-1EC21FD5EEE2

Q35492010-1567603C-703A-4E03-BA7D-D5002286D58D

Q35492010-1589358C-6638-48EC-9CA9-FB95FE936566

Q35492010-258A8A00-84B5-47CE-9538-CD5FAAD87742

Q35492010-2C2D5AC3-DA7D-4F13-8A4D-30C55224FD15

Q35492010-2E649A5F-4D34-4D39-9AD7-975AB376AA30

P304

Q35492010-394744FE-C50B-454D-88CD-539967218573

P31

Q35492010-84A46F5C-AAFF-4170-BFBE-159812C37850

P356

Q35492010-5CBDA404-7C80-420B-94D0-F7A149C9E8DE

P433

Q35492010-0E52A03A-A8A8-40BD-8B65-97F6B2552FF3

P478

Q35492010-1F6E5005-79D3-4E14-AED0-3B07804EC6EC

P50

Q35492010-DACDA45D-6078-49D0-AB16-EEA33F3AB100

Q35492010-F30A59C1-B28D-4697-8170-04D7447687EB

P577

Q35492010-9EE5CB34-6226-444A-99F9-F6EDF042DFEF

P5875

Q35492010-A47D4076-2C34-4D95-B09B-E7A9E34138F8

P698

Q35492010-1A95CFE0-B407-4CE8-BB8F-9EFDC18C2F36

P921

Q35492010-052D6932-AE22-43B5-914A-E42F51193A13

P932

Q35492010-EF6E977C-00D5-4BEA-93BD-4A3C5CD3128E

P356

P1433

P1476

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

@en

P2093

Adi F Gazdar

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Katayama

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Müge Celiktaş

http://www.w3.org/2001/XMLSchema#string

Samir M Hanash

http://www.w3.org/2001/XMLSchema#string

P2860

Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2

Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer

The p53 pathway as a target in cancer therapeutics: obstacles and promise

Epithelial-mesenchymal transitions in development and disease

p53 regulates mitochondrial respiration

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

P304

2750-2759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.201400378

http://www.w3.org/2001/XMLSchema#string

P433

23-24

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267158860

http://www.w3.org/2001/XMLSchema#string

P698

25331784

http://www.w3.org/2001/XMLSchema#string

P921

P932

4403731

http://www.w3.org/2001/XMLSchema#string